FDCC
MLAB icon

Foster Dykema Cabot & Co’s Mesa Laboratories MLAB Stock Holding History

Foster Dykema Cabot & Co’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21
Closed -$3K – 366
2023
Q2 		$3K Buy
+21
New +$3.2K ﹤0.01% 340

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Foster Dykema Cabot & Co's MLAB Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of Mesa Laboratories (MLAB) in Q3 2023, closing a stake of 21 shares — an estimated $3K sold.

Foster Dykema Cabot & Co first reported a position in MLAB in Q2 2023 and held it in 1 quarter. The position peaked at $3K in Q2 2023. 154 funds tracked by Wall St. Rank hold MLAB as of Q3 2023.

  • Foster Dykema Cabot & Co reported no remaining Mesa Laboratories position as of Q3 2023 after selling out during the quarter.
  • Foster Dykema Cabot & Co sold 21 Mesa Laboratories shares in Q3 2023, an estimated $3K.
  • Foster Dykema Cabot & Co first reported a position in Mesa Laboratories in Q2 2023 and held it in 1 quarter.
  • Foster Dykema Cabot & Co's Mesa Laboratories position peaked at $3K in Q2 2023.
  • 154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.